EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Unlocking the potential of blood-stage vaccines for malaria elimination

Shrikant Nema iD, Sumit Rathore, Asif Mohmmed, Pawan Malhotra

Transactions of The Royal Society of Tropical Medicine and Hygiene · 2025

DOI: 10.1093/trstmh/traf013 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Transactions of The Royal Society of Tropical Medicine and Hygiene, 2025. Verfasst von Shrikant Nema und 3 weiteren Autor:innen. Beteiligte Einrichtung: Malaria Biology Group, International Center for Genetic Engineering and Biotechnology (ICGEB), Aruna Asaf Ali Marg, 110067 New Delhi, India. Hauptthemen laut MEDLINE: Malaria Vaccines, Malaria, Malaria, Falciparum, Plasmodium falciparum. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, DBT-Wellcome Trust India Alliance, DBT/Wellcome Trust India Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malaria vaccines are crucial for advancing public health and achieving malaria elimination. Currently, pre-erythrocytic vaccines like RTS, S/AS01 and R21/Matrix-M are in use, but their effectiveness is limited. Ongoing research on blood-stage vaccine candidates such as RH5, MSP1 and MSP3 has shown promising results. Incorporating a blood-stage vaccine could greatly enhance malaria control by targeting the symptomatic phase of the infection, providing additional protection alongside pre-erythrocytic vaccines and other control methods. Understanding the structural biology and immunological interactions of blood-stage antigens is essential for developing effective vaccines. Combining pre-erythrocytic and erythrocytic-stage vaccines could lead to better protection, improved public health outcomes and significant progress toward malaria elimination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Malaria VaccinesMalariaMalaria, FalciparumPlasmodium falciparumDisease EradicationHumansAntigens, ProtozoanAnimals

Stichwörter der Autor:innen

R21RTSSblood-stage vaccinemalaria elimination

Substanzen

Malaria VaccinesAntigens, Protozoan

Autor:innen und Institutionen

  • Malaria Biology Group, International Center for Genetic Engineering and Biotechnology (ICGEB), Aruna Asaf Ali Marg, 110067 New Delhi, India.
  • Department of Biotechnology, All India Institute of Medical Science (AIIMS), Ansari Nagar, 110029 New Delhi, India.
  • Parasite Cell Biology Group, International Center for Genetic Engineering and Biotechnology (ICGEB), Aruna Asaf Ali Marg, 110067 New Delhi, India.

ORCID-Profile: Shrikant Nema

Förderung

  • Wellcome Trust
  • DBT-Wellcome Trust India Alliance
  • DBT/Wellcome Trust India Alliance

Zitieren

APA

Nema, S., Rathore, S., Mohmmed, A., & Malhotra, P. (2025). Unlocking the potential of blood-stage vaccines for malaria elimination. Transactions of The Royal Society of Tropical Medicine and Hygiene. https://doi.org/10.1093/trstmh/traf013

Vancouver

Nema S, Rathore S, Mohmmed A, Malhotra P. Unlocking the potential of blood-stage vaccines for malaria elimination. Transactions of The Royal Society of Tropical Medicine and Hygiene. 2025. doi:10.1093/trstmh/traf013

BibTeX
@article{Nema2025,
  author = {Nema, Shrikant and Rathore, Sumit and Mohmmed, Asif and Malhotra, Pawan},
  title = {Unlocking the potential of blood-stage vaccines for malaria elimination},
  journal = {Transactions of The Royal Society of Tropical Medicine and Hygiene},
  year = {2025},
  doi = {10.1093/trstmh/traf013}
}
Kostenlos starten →